News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Hofmeister Robert
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| Hofmeister Robert (Director) has filed a Form 4 on Alaunos Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.48, valued at
$48k
|
|
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2020 |
4
| Hofmeister Robert (Chief Scientific Officer) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Exercised 7,000 options to buy
@ $0.74, valued at
$5.2k
|
|
| 12/11/2020 |
4
| Hofmeister Robert (Chief Scientific Officer) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Granted 76,000 options to buy
@ $31.83, valued at
$2.4M
|
|
| 11/13/2020 |
4
| Hofmeister Robert (Chief Scientific Officer) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Sold 9,998 shares
@ $25.1, valued at
$250.9k
Sold 10,002 shares
@ $25.1, valued at
$251.1k
Exercised 9,998 options to buy
@ $0.74, valued at
$7.4k
Exercised 10,002 options to buy
@ $0.74, valued at
$7.4k
|
|
| 11/02/2020 |
4
| Hofmeister Robert (Chief Science Officer) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Sold 20,000 shares
@ $19.1, valued at
$382k
Exercised 20,000 options to buy
@ $0.74, valued at
$14.8k
|
|
| 12/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/12/2019 |
4
| Hofmeister Robert (Chief Scientific Officer) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Granted 127,512 options to buy
@ $16.11, valued at
$2.1M
|
|
|
|